Ethylene Glycol

Ethylene Glycol

SCHEMBL2776977

C=CS(=O)(=O)C=C.OCCO

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8764182 0.82
SCHEMBL23101 0.82
SCHEMBL3512818 0.82
SCHEMBL27756386 0.82
Vinylsulfonic Acid SCHEMBL4057155 0.80 TSHR (0.33) TSHR
SCHEMBL28251068 0.79 ALDH1A1 (0.38) TSHR
Sulfuric Acid SCHEMBL25265040 0.79 CA5A (0.46) TSHR
Methyl Alcohol SCHEMBL9253309 0.79 ALDH1A1 (0.33)
SCHEMBL18587180 0.78
Ammonia Solution, Strong SCHEMBL1587516 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9017726-B2 Biodegradable and thermosensitive poly(organophosphazene)-superparamagnetic nanoparticle complex, preparation method and use thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-04-28 US claimed
US-8586020-B2 Poly(organophosphazene) composition for biomaterials KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2013-11-19 US claimed
US-20130004455-A1 POLY(ORGANOPHOSPHAZENE) COMPOSITION FOR BIOMATERIALS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2013-01-03 US claimed
EP-2540764-A2 Poly(organophosphazene) composition for biomaterials Korea Institute of Science and Technology (KR) 2013-01-02 EP claimed
US-8313771-B2 Phosphazene hydrogels with chemical corss-link, preparation method thereof and use thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2012-11-20 US claimed
US-20120202263-A1 Bioactive Macromers and Hydrogels and Methods for Producing Same THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2012-08-09 US claimed
US-20120121517-A1 BIODEGRADABLE AND THERMOSENSITIVE POLY(ORGANOPHOSPHAZENE)-SUPERPARAMAGNETIC NANOPARTICLE COMPLEX, PREPARATION METHOD AND USE THEREOF Korean Institute of Science and Technology of Seoul, Republic of Korea 2012-05-17 US claimed
US-20100297155-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS-LINK, PREPARATION METHOD THEREOF AND USE THEREOF DECA ITALIA S.R.L. (IT) 2010-11-25 US claimed
EP-2155806-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS -LINK, PREPARATION METHOD THEREOF AND USE THEREOF Korea Institute of Science and Technology (KR) 2010-02-24 EP claimed
WO-2008153278-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS -LINK, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2008-12-18 WO claimed
EP-0906122-B1 ACTIVATED LINKERS AND METHODS FOR MAKING AND PURIFYING THE SAME AMGEN INC (US) 2003-09-10 EP claimed
JP-2000506851-A 2000-06-06 JP claimed
US-5935564-A USING ABSORBER RESIN HAVING A BUTYL, OCTYL, PHENYL OR ETHER PENDANT GROUP TO PURIFY A POLYOXYETHYLENE GLYCOL HAVING SULFONYL CHLORIDE OR VINYLSULFONE END GROUPS FOR REACTING WITH AN INHIBITOR OF TUMOR NECROSIS FACTOR AMGEN INC. (US) 1999-08-10 US claimed
EP-0906122-A2 ACTIVATED LINKERS AND METHODS FOR MAKING AND PURIFYING THE SAME AMGEN INC. (US) 1999-04-07 EP claimed
US-5747639-A METHACRYLATE BACKBONE POLYMER AND BIS/VINYL SULFONE FOR CHROMATOGRAPHIC COLUMNS AMGEN BOULDER INC. (US) 1998-05-05 US claimed
WO-1997032607-A2 ACTIVATED LINKERS AND METHODS FOR MAKING AND PURIFYING THE SAME AMGEN INC. (US) 1997-09-12 WO claimed
WO-2024030186-A1 COMPOSITIONS AND METHODS RELATED TO MICROGELS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-02-08 WO disclosed
EP-3866835-B1 METHOD FOR MONITORING AUTOIMMUNE DISEASE UNIV MICHIGAN REGENTS (US) 2024-01-03 EP disclosed
WO-2006116156-A2 TOXIN PEPTIDES WITH EXTENDED BLOOD HALFLIFE AMGEN INC. (US) 2006-11-02 WO disclosed
EP-0906122-B1 ACTIVATED LINKERS AND METHODS FOR MAKING AND PURIFYING THE SAME AMGEN INC (US) 2003-09-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130004455-A1 POLY(ORGANOPHOSPHAZENE) COMPOSITION FOR BIOMATERIALS PHOSPHO1, PGLS, PHYKPL TSHR 4580/4885
US-20120121517-A1 BIODEGRADABLE AND THERMOSENSITIVE POLY(ORGANOPHOSPHAZENE)-SUPERPARAMAGNETIC NANOPARTICLE COMPLEX, PREPARATION METHOD AND USE THEREOF PHOSPHO1, HSPA2, FEM1B TSHR 929/4885
US-20100297155-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS-LINK, PREPARATION METHOD THEREOF AND USE THEREOF PRUNE1, PHYKPL, PAPSS1 TSHR 3405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.